StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
LAB

Standard BioTools Inc.

LAB Nasdaq Pharmaceutical Preparations EDGAR ↗
$0.87
-0.03 -3.78%

Key statistics

from XBRL data in SEC filings
Market cap
$338M
Revenue (TTM)
$86.3M
Net income (TTM)
$78.2M
EPS (TTM)
$0.20
P/E ratio
4.3
Dividend yield
Free cash flow
-$82.6M
Cash
$266M
Total assets
$639M
Gross margin
49.6%
52-week range
$0.70 – $1.72

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K/A Jul 29, 2026 8-K Entered a material agreement; Regulation FD disclosure Jul 28, 2026 8-K Delisting notice or listing-rule failure Jul 24, 2026 8-K Director or officer change; Shareholder vote results Jun 18, 2026 8-K Entered a material agreement; Unregistered sale of equity; Change in control; Director or officer change; Regulation FD disclosure Jun 8, 2026 8-K Other events Jun 5, 2026 8-K Director or officer change Jun 3, 2026 8-K Director or officer change May 28, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 5, 2026 8-K Delisting notice or listing-rule failure Apr 24, 2026 10-K Fiscal year ended 2025-12-31 Mar 16, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 24, 2026 8-K/A FORM 8-K/A Feb 5, 2026 8-K Completed an acquisition or disposition; Results of operations (earnings release); Regulation FD disclosure Jan 30, 2026 8-K Results of operations (earnings release) Jan 8, 2026 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2025 8-K Exit or disposal costs Sep 17, 2025 8-K Exit or disposal costs Sep 3, 2025 10-Q Quarter ended 2025-06-30 Aug 15, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 11, 2025 8-K Director or officer change Aug 1, 2025 8-K Entered a material agreement; Regulation FD disclosure Jun 23, 2025 8-K Director or officer change; Shareholder vote results Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 11, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 26, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Director or officer change Jan 10, 2025 8-K Dec 20, 2024 8-K Director or officer change Nov 7, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 30, 2024 8-K Regulation FD disclosure Sep 5, 2024 8-K Director or officer change Aug 30, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Director or officer change Jul 31, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jul 31, 2024